Kun Wang
Guangdong Provincial People's Hospital · Guangdong Provincial People's Hospital Guangzhou, · Chung Shan Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
19
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
9 more share only the name and are not shown
Trial papers in breast cancer
41
PubMed author-name match
Trials
Studies that name Kun Wang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:05 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07410169 · Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral NeuropathyGuangdong Provincial People's Hospital · recruiting · Breast Cancer, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Paclitaxel-induced Peripheral Neuropathy · principal investigator
- N/ANCT07077018 · Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast CancerGuangdong Provincial People's Hospital · not yet recruiting · Fasting-Mimicking Diet, Breast Cancer, Neoadjuvant Chemotherapy · principal investigator
- N/ANCT06811857 · This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer SurgeryGuangdong Provincial People's Hospital · not yet recruiting · Flap Necrosis, Flap Ischemia · study chair
- Ph1/Ph2NCT06811870 · A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer PatientsGuangdong Provincial People's Hospital · recruiting · Breast Cancers · principal investigator
- Ph3NCT06533384 · PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBCGuangdong Provincial People's Hospital · recruiting · Triple-negative Breast Cancer · study chair
- N/ANCT05841186 · Correlation of Timing of Pegfilgrastim Administration and PIBP.Guangdong Provincial People's Hospital · unknown · Pegfilgrastim, Bone Pain, Chemotherapy · principal investigator
- N/ANCT05680532 · The Improvement of Black Raspberry in Obese and Mild AZ Patients Infected With H. PyloriChung Shan Medical University · completed · Alzheimer Disease, H Pylori Infection · principal investigator
- N/ANCT05084443 · Effect of Roselle-based Drink on Blood Pressure and SkinChung Shan Medical University · completed · Other Skin and Subcutaneous Infections · principal investigator
- Ph3NCT04951245 · Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node BiopsyGuangdong Provincial People's Hospital · completed · Breast Cancer · study chair
- N/ANCT04643613 · Effect of Nutritional Formula (Protison) on Various Cancer Patients: A Randomized Clinical TrialChung Shan Medical University · completed · Cancer · principal investigator
- Ph2NCT04637308 · Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel ChemotherapyGuangdong Provincial People's Hospital · completed · Fluid Retention · principal investigator
- Ph2NCT04565600 · Prevention of Taxane-associated Acute Pain Syndrome With EtoricoxibGuangdong Provincial People's Hospital · completed · Pain Syndrome · principal investigator
- Ph3NCT04263298 · Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast CancerHerui Yao · recruiting · Metastatic Breast Cancer · principal investigator
- N/ANCT04218253 · Clinical Application of Nutrition Support Package Before HepatectomyTianjin Medical University Cancer Institute and Hospital · unknown · Liver Neoplasms, Nutrition Therapy, Hepatectomy · study chair
- Ph2NCT03243838 · Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast CancerGuangdong Provincial People's Hospital · completed · Triple-Negative Breast Cancer · study director
- N/ANCT03162133 · Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor TherapyGuangdong Provincial People's Hospital · completed · Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy · principal investigator
- Ph2NCT03140553 · TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast CancerGuangdong Provincial People's Hospital · completed · HER2-Positive Breast Cancer · principal investigator
- N/ANCT02634242 · Study on the Antiaging Effect of Chinese Herb DrinkChung Shan Medical University · completed · Gynecological Disorders · study chair
- Ph2NCT02059876 · Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerGuangdong Provincial People's Hospital · unknown · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:05 UTC. The ranking covers the 200 most relevant of 41 PubMed records, and a shared surname and initials can bring in a namesake. All 41 on PubMed
- Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.Nat Med · 2024134 citationsRCR 14.2
- A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer.Eur J Cancer · 2013117 citationsRCR 3.0
- Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.J Clin Oncol · 2014102 citationsRCR 2.8
- 82 citationsRCR 5.1
- 63 citationsRCR 3.6
- 59 citationsRCR 4.2
- 55 citationsRCR 10.1
- Functional connectivity change of brain default mode network in breast cancer patients after chemotherapy.Neuroradiology · 201649 citationsRCR 1.9
- Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.Mol Cell Proteomics · 201546 citationsRCR 1.3
- Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial.Ann Surg Oncol · 201946 citationsRCR 2.2